Project Grant R01AR085556
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $134,261 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through March 31, 2028. The research project, titled "Genetic and Genomic Analysis of Electron Transport Chain Complex II Functions in Mammalian Skin Development,"...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 2, 2026, through May 31, 2028. The award supports investigator-initiated biomedical research examining the mechanisms linking diet-induced dyslipidemia to skin inflammation in psoriasis, with a focus on...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Washington University a Project Grant totaling $258,070 on September 26, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to support a five-year physician-scientist training initiative. The award funds a mentored research project examining the role of centrosomal protein CEP43 in maintaining epidermal integrity and its connection to...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Leland Stanford Junior University a Project Grant of $102,341 on September 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports research on RNA-dependent protein assemblies in epidermal homeostasis, with completion targeted for June 30, 2027. The project addresses mechanisms of epidermal dysfunction...
- Federal Project Grant Award Summary New York University School of Medicine received a $148,062 project grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded September 30, 2025, with completion scheduled for May 31, 2028. The award funds research to decode the mechanistic role of transcription factors in encoding inflammatory memory within human epithelial cells,...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a $250,396 Project Grant (R21 mechanism) effective September 5, 2025, through August 31, 2027, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds research to unravel epigenetic and transcriptional control mechanisms in skin cells from populations with historically understudied...
- Federal Grant Award Summary Northwestern University Feinberg School of Medicine received a $298,166 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025 through August 31, 2030. This National Research Service Award (NRSA) establishes a rheumatology research training program designed to develop a diverse pool of postdoctoral...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $559,795 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective May 1, 2026, through January 31, 2031. The grant supports biomedical research investigating cell mechanics-mediated regulation of hair follicle stem cells (HFSCs) during homeostasis and aging. The research focuses on the role of microRNA-205 in regulating the extracellular matrix...
- Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $224,100 Project Grant to the Regents of the University of California at Riverside on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This three-year research initiative, with completion targeted for August 31, 2028, focuses on identifying epigenetic factors that control epidermal stem cell longevity in adult skin....
- Federal Project Grant Award Summary Arizona State University received a $792,666 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 2, 2025, with completion targeted for May 31, 2030. The research project, titled "A Mechanistic Investigation of SERPINB3 and Its Role in Psoriasis," will conduct fundamental scientific...
Northwestern University's Sponsored Research Division received a $524,335 Project Grant award dated June 5, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research through April 30, 2031, investigating the dynamic regulation of epidermal differentiation genes by cell-state-specific PBAF (polybromo-associated BAF) chromatin remodeling complex interactome. The research addresses molecular mechanisms governing the transition between gene repression and activation during epidermal differentiation, with direct implications for understanding and treating prevalent skin disorders including psoriasis, eczema, and cutaneous squamous cell carcinoma. The project delivers fundamental research products focused on elucidating PBAF's functional switch from repressor to activator in differentiation regulation. Key deliverables include mechanistic characterization of upstream regulatory controls governing PBAF-PIAS1 (protein inhibitor of activated signal transducer and activator of transcription 1) association and dissociation, identification of downstream impacts of this protein interaction on epidermal differentiation, and investigation of ubiquitination-mediated regulation of protein stability. Research outputs will advance molecular understanding of epidermal homeostasis maintenance and contribute to development of targeted therapeutic strategies for skin diseases.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $524.3k | 6/9/26 |